Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person

Review Article | By Lenka K, Alena M, Marek S et al.

Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label，blinded-outcome，randomised trial

Clinical Trial | By JM Liu, Y Li; ESPRIT Collaborative Group.

Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Clinical Trial | By J Wen, S Dohad, R Shlofmitz et al.